Wentao Yao

机构：Hebei General Hospital · ORCID：0000-0001-7832-8290

发表论文 17 篇 · 总被引 383 次 · h-index 6

代表论文

• Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives (2024 · Signal Transduction and Targeted Therapy · 被引 243)
• From degenerative disease to malignant tumors: Insight to the function of ApoE (2022 · Biomedicine & Pharmacotherapy · 被引 70)
• Ligustrazine exerts neuroprotective effects via circ_0008146/miR-709/Cx3cr1 axis to inhibit cell apoptosis and inflammation after cerebral ischemia/reperfusion injury (2022 · Brain Research Bulletin · 被引 21)
• C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma (2023 · Frontiers in Genetics · 被引 18)
• Circulating miRNA‐3552 as a Potential Biomarker for Ischemic Stroke in Rats (2020 · BioMed Research International · 被引 13)
• A systematic review of cardiovascular toxicities induced by cancer immune therapies: Underlying mechanisms, clinical manifestations and therapeutic approaches (2024 · Seminars in Cancer Biology · 被引 6)